ATE516804T1 - Optisch aktive isomere von ketotifen und deren therapeutisch wirksame metabolite - Google Patents
Optisch aktive isomere von ketotifen und deren therapeutisch wirksame metaboliteInfo
- Publication number
- ATE516804T1 ATE516804T1 AT00966709T AT00966709T ATE516804T1 AT E516804 T1 ATE516804 T1 AT E516804T1 AT 00966709 T AT00966709 T AT 00966709T AT 00966709 T AT00966709 T AT 00966709T AT E516804 T1 ATE516804 T1 AT E516804T1
- Authority
- AT
- Austria
- Prior art keywords
- ketotifen
- optically active
- active isomers
- metabolites
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15356699P | 1999-09-13 | 1999-09-13 | |
US19790500P | 2000-04-15 | 2000-04-15 | |
US19798500P | 2000-04-15 | 2000-04-15 | |
US19790600P | 2000-04-15 | 2000-04-15 | |
US19736300P | 2000-04-15 | 2000-04-15 | |
PCT/US2000/024892 WO2001019367A1 (en) | 1999-09-13 | 2000-09-12 | Optically active isomers of ketotifen and therapeutically active metabolites thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE516804T1 true ATE516804T1 (de) | 2011-08-15 |
Family
ID=27538454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00966709T ATE516804T1 (de) | 1999-09-13 | 2000-09-12 | Optisch aktive isomere von ketotifen und deren therapeutisch wirksame metabolite |
Country Status (18)
Country | Link |
---|---|
US (3) | US7226934B1 (de) |
EP (1) | EP1218007B1 (de) |
JP (1) | JP5116928B2 (de) |
CN (1) | CN1391475A (de) |
AR (1) | AR034396A1 (de) |
AT (1) | ATE516804T1 (de) |
AU (1) | AU782816B2 (de) |
BR (1) | BR0013935A (de) |
CA (1) | CA2383222C (de) |
CY (1) | CY1112605T1 (de) |
DK (1) | DK1218007T3 (de) |
HU (1) | HUP0202671A3 (de) |
IL (2) | IL148368A0 (de) |
MX (1) | MXPA02002658A (de) |
MY (1) | MY134888A (de) |
PL (1) | PL353586A1 (de) |
PT (1) | PT1218007E (de) |
WO (1) | WO2001019367A1 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1218007E (pt) * | 1999-09-13 | 2011-10-27 | Bridge Pharma Inc | Isómeros opticamente activos de cetotifeno e metabolitos terapeuticamente activos dos mesmos |
US20100166804A1 (en) * | 2007-05-23 | 2010-07-01 | Dennis Penn | Methods |
WO2009142772A2 (en) | 2008-05-23 | 2009-11-26 | Mastcell Pharmaceuticals, Inc. | Methods and treatment for allergies and inflammation associated with gastrointestinal diseases |
JP5550641B2 (ja) * | 2008-06-13 | 2014-07-16 | ケース ウェスタン リザーブ ユニバーシティ | 角膜炎症を治療するための組成物および方法 |
WO2010047681A1 (en) * | 2008-10-24 | 2010-04-29 | Bridge Pharma, Inc. | Treating xerophthalmia with norketotifen |
US8765787B2 (en) * | 2008-11-21 | 2014-07-01 | Bridge Pharma, Inc. | Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen |
WO2010107525A1 (en) * | 2009-03-17 | 2010-09-23 | Aciex Therapeutics, Inc. | Ophthalmic formulations of ketotifen and methods of use |
US9296731B2 (en) * | 2011-06-28 | 2016-03-29 | Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. | Anti-allergy benzocycloheptathiophene derivatives |
US8557846B1 (en) | 2012-10-23 | 2013-10-15 | Bridge Pharma, Inc. | Medicinal treatment of dermal diseases in dogs |
US8778971B2 (en) * | 2012-10-23 | 2014-07-15 | Bridge Pharma, Inc. | Medicinal treatment of dermal diseases in companion animals |
US20150272941A1 (en) | 2012-10-30 | 2015-10-01 | Bridge Pharma, Inc. | Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen |
US20140120121A1 (en) * | 2012-10-30 | 2014-05-01 | Bridge Pharma, Inc. | Medicinal treatment of atopic inflammatory diseases |
US9345697B2 (en) | 2013-08-06 | 2016-05-24 | Bridge Pharma, Inc. | Methods of treatment of non-histaminic pruritus |
US9138431B2 (en) * | 2013-08-06 | 2015-09-22 | Bridge Pharma, Inc. | Methods of treatment of histamine H-4 receptor-related pruritus |
US9439895B2 (en) | 2013-08-06 | 2016-09-13 | Bridge Pharma, Inc. | Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients |
CN104059056B (zh) * | 2014-06-26 | 2017-08-25 | 福建省闽东力捷迅药业有限公司 | 一种富马酸卢帕替芬晶型b及其制备方法 |
CA2988564C (en) | 2015-06-11 | 2021-10-05 | Bridge Pharma, Inc. | Methods of treatment of non-histaminic pruritus in mammals |
US9694003B2 (en) | 2015-10-15 | 2017-07-04 | Bridge Pharma, Inc. | Formulations and methods for treating high intraocular pressure |
CN106243096B (zh) * | 2016-07-29 | 2019-11-29 | 上海璃道医药科技有限公司 | 三环类药物的新用途 |
RU2760682C2 (ru) | 2016-09-08 | 2021-11-29 | Имерго Терапьютикс, Инк. | Стабилизаторы тучных клеток лечения гиперцитокинемии и вирусной инфекции |
WO2018075574A1 (en) | 2016-10-18 | 2018-04-26 | Emergo Therapeutics, Inc. | Mast cell stabilizers for treatment of chronic inflammatory conditions |
US20200268734A1 (en) * | 2019-02-22 | 2020-08-27 | Bridge Pharma, Inc. | Methods of treatment of respiratory disorders |
US10959992B2 (en) | 2019-02-22 | 2021-03-30 | Bridge Pharma Inc. | Methods of treatment of asthma and COPD |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1089483A (en) | 1964-02-04 | 1967-11-01 | Sandoz Ltd | Improvements in or relating to 4h-benzo(4,5)cyclohepta (1,2-b) thiophene derivatives |
FR1447527A (fr) | 1964-08-11 | 1966-07-29 | Sandoz Sa | Nouveaux benzo-cyclohepta-thiophènes et leur préparation |
CH531000A (de) | 1970-03-11 | 1972-11-30 | Sandoz Ag | Verfahren zur Herstellung neuer Benzocycloheptathiophene |
BE794377A (fr) * | 1972-01-24 | 1973-07-23 | Sandoz Sa | Nouveaux derives du benzo-cyclohepta-thiophene |
US3994974A (en) | 1972-02-05 | 1976-11-30 | Yamanouchi Pharmaceutical Co., Ltd. | α-Aminomethylbenzyl alcohol derivatives |
US4073915A (en) | 1975-05-20 | 1978-02-14 | Sandoz Ltd. | Treating asthma |
US4128549A (en) | 1976-02-27 | 1978-12-05 | Sandoz Ltd. | Precursors of 4-(1-alkyl-4-piperidylidene-4H-benzo[4,5]cyclohepta-[1,2-b]thiophen-10(9H)-ones |
CS263993B1 (cs) | 1988-03-11 | 1989-05-12 | Polivka Zdenek | Způsob přípravy čistých enantiomerů 4- (l-meíhyl-4-piperidyliden) -4,9-dihydrobenzo [ 4,5) cyklohepta [ 1,2-b ] - thiofen-lQ-onu |
ATE141599T1 (de) | 1988-04-28 | 1996-09-15 | Schering Corp | Kondensierte polyzyklische verbindungen, zusammenstellungen, verfahren zur herstellung und deren anwendung als paf-antagonistische, antihistaminische und/oder anti-inflammatorische agenzien |
GB9012926D0 (en) * | 1990-06-09 | 1990-08-01 | Scras | Pyrrolo-pyridine derivatives |
CA2093646A1 (en) * | 1990-10-10 | 1992-04-11 | Jesse K. Wong | Bis-benzo cyclohepta piperidylidene, piperidine and piperazine compounds, compositions and methods of use |
CA2381329C (en) * | 1991-12-12 | 2003-04-15 | Glaxo Group Limited | Medicaments |
AU673660C (en) | 1991-12-18 | 2002-07-25 | Astrazeneca Ab | New combination of formoterol and budesonide |
US6040344A (en) | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
CA2283663C (en) * | 1997-04-03 | 2006-07-25 | Bridge Pharma, Inc. | Benzocycloheptathiophene compounds |
WO1998056381A1 (en) * | 1997-06-09 | 1998-12-17 | Bridge Pharma, Inc. | Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use |
PT1218007E (pt) | 1999-09-13 | 2011-10-27 | Bridge Pharma Inc | Isómeros opticamente activos de cetotifeno e metabolitos terapeuticamente activos dos mesmos |
-
2000
- 2000-09-12 PT PT00966709T patent/PT1218007E/pt unknown
- 2000-09-12 US US10/069,663 patent/US7226934B1/en not_active Expired - Fee Related
- 2000-09-12 JP JP2001523001A patent/JP5116928B2/ja not_active Expired - Fee Related
- 2000-09-12 AT AT00966709T patent/ATE516804T1/de active
- 2000-09-12 MX MXPA02002658A patent/MXPA02002658A/es active IP Right Grant
- 2000-09-12 BR BR0013935-1A patent/BR0013935A/pt not_active Application Discontinuation
- 2000-09-12 PL PL00353586A patent/PL353586A1/xx not_active Application Discontinuation
- 2000-09-12 HU HU0202671A patent/HUP0202671A3/hu unknown
- 2000-09-12 CA CA002383222A patent/CA2383222C/en not_active Expired - Fee Related
- 2000-09-12 IL IL14836800A patent/IL148368A0/xx active IP Right Grant
- 2000-09-12 EP EP00966709A patent/EP1218007B1/de not_active Expired - Lifetime
- 2000-09-12 WO PCT/US2000/024892 patent/WO2001019367A1/en active IP Right Grant
- 2000-09-12 AU AU77014/00A patent/AU782816B2/en not_active Ceased
- 2000-09-12 DK DK00966709.8T patent/DK1218007T3/da active
- 2000-09-12 CN CN00815422A patent/CN1391475A/zh active Pending
- 2000-09-13 MY MYPI20004252A patent/MY134888A/en unknown
- 2000-09-13 AR ARP000104790A patent/AR034396A1/es not_active Application Discontinuation
-
2002
- 2002-02-25 IL IL148368A patent/IL148368A/en not_active IP Right Cessation
-
2007
- 2007-04-30 US US11/796,998 patent/US7557128B2/en not_active Expired - Fee Related
-
2009
- 2009-02-12 US US12/378,231 patent/US7872025B2/en not_active Expired - Fee Related
-
2011
- 2011-10-17 CY CY20111100984T patent/CY1112605T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL353586A1 (en) | 2003-12-01 |
JP5116928B2 (ja) | 2013-01-09 |
MXPA02002658A (es) | 2002-10-23 |
IL148368A0 (en) | 2002-09-12 |
AU782816B2 (en) | 2005-09-01 |
CA2383222C (en) | 2008-11-18 |
US7226934B1 (en) | 2007-06-05 |
CN1391475A (zh) | 2003-01-15 |
MY134888A (en) | 2007-12-31 |
AR034396A1 (es) | 2004-02-25 |
CA2383222A1 (en) | 2001-03-22 |
AU7701400A (en) | 2001-04-17 |
JP2003509369A (ja) | 2003-03-11 |
WO2001019367A1 (en) | 2001-03-22 |
US7557128B2 (en) | 2009-07-07 |
BR0013935A (pt) | 2002-05-14 |
US20080287498A1 (en) | 2008-11-20 |
IL148368A (en) | 2007-10-31 |
DK1218007T3 (da) | 2011-11-07 |
US7872025B2 (en) | 2011-01-18 |
HUP0202671A2 (hu) | 2002-11-28 |
EP1218007B1 (de) | 2011-07-20 |
PT1218007E (pt) | 2011-10-27 |
EP1218007A1 (de) | 2002-07-03 |
HUP0202671A3 (en) | 2005-01-28 |
CY1112605T1 (el) | 2016-02-10 |
EP1218007A4 (de) | 2003-04-09 |
US20090149502A1 (en) | 2009-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE516804T1 (de) | Optisch aktive isomere von ketotifen und deren therapeutisch wirksame metabolite | |
NL300952I2 (nl) | Peramivir en farmaceutisch aanvaardbare zouten daarvan | |
IS2142B (is) | Nýtt form S-ómeprasóls | |
DK2455083T3 (da) | Farmaceutisk sammensætning til dermal anvendelse omfattende calcipotriol og betamethason til behandling af psoriasis | |
DK1328259T3 (da) | Transdermale terapeutiske systemer med lysfølsomme aktivstoffer | |
DE69905906D1 (de) | Kombination von zwei oder mehreren wirkstoffen unter verwendung von mikrokapsel-formulierungen | |
DE59902343D1 (de) | Aktivmatrix-flüssigkristallanzeige | |
DE59905565D1 (de) | Aktivmatrix-flüssigkristallanzeige | |
DE69815524D1 (de) | Haftende mikrokapseln enthaltend biologisch aktive substanzen | |
DE60028022D1 (de) | Herstellung von biologisch aktiven molekülen | |
DE69813602D1 (de) | Venlafaxinhaltiges arzneimittel mit verlängerter wirkstoffabgabe | |
DE60045459D1 (de) | Wiederablösbarer Klebstoff und wiederablösbare Klebefolie | |
DE69834164D1 (de) | Aktivmatrix-Flüssigkristallanzeige | |
DE60025627D1 (de) | Pharmazeutische lösung von levosimendan | |
DE69935415D1 (de) | Aktivmatrix-flüssigkristall-anzeigevorrichtungen | |
DK0777457T3 (da) | Anvendelse af glyceryltriacetat til behandling af onychomykoser | |
DE60232290D1 (de) | Kontrollierte Auflösung von Wirkstoffen | |
FI972330A (fi) | Biasjänniteohjattuja rinnakkaisia aktiivikomponentteja | |
NO980923D0 (no) | Optisk aktivt fenylpyrimidin-derivat som analgetisk middel | |
EE200100623A (et) | Melatoniini terapeutiline kasutamine | |
PT1178981E (pt) | 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos | |
ID30131A (id) | Penggunaan zat penurun kolesterol | |
DE69838066D1 (de) | Behandlung der diabetes mit thiazolidindione und sulphonylurea | |
DE69837089D1 (de) | Behandlung der diabetes mit thiazolidindione und sulphonylurea | |
DK0939622T3 (da) | Porøse mikrokapsler og deres anvendelse som terapeutiske og diagnostiske bærestoffer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1218007 Country of ref document: EP |